SERPINB1 Antibody

What is SERPINB1 and what are its primary biological functions?

SERPINB1, also known as Leukocyte Elastase Inhibitor (LEI), Monocyte/neutrophil elastase inhibitor (M/NEI), or Peptidase inhibitor 2 (PI2), is a member of the serpin family of protease inhibitors. It functions primarily as a neutrophil serine protease inhibitor that plays essential roles in regulating innate immune responses, inflammation, and cellular homeostasis .

SERPINB1 acts as a cellular protector against proteases released into the cytoplasm during stress or infection. These proteases are important for killing microbes, but when released from granules, they can destroy host proteins and contribute to mortality . The protein regulates several proteolytic enzymes, including neutrophil elastase, cathepsin G, proteinase-3, chymase, chymotrypsin, and kallikrein-3 . Additionally, SERPINB1 functions as a potent intracellular inhibitor of granzyme H and limits the activity of inflammatory caspases (CASP1, CASP4, and CASP5) by suppressing their CARD oligomerization and enzymatic activation .

More recently, research has revealed that SERPINB1 possesses dual enzymatic capabilities: an antiprotease activity dependent on its reactive site loop (analogous to other serpins) and an endonuclease activity that becomes active when its reactive site loop is cleaved . This conformational change also exposes a bipartite nuclear localization signal, enabling the protein to translocate to the nucleus .

What are the most common experimental applications for SERPINB1 antibodies?

SERPINB1 antibodies are employed in several key experimental techniques:

• Western Blotting (WB): Used to detect and quantify SERPINB1 protein expression levels in cell or tissue lysates, typically showing bands at approximately 43-47 kDa .

• Immunohistochemistry (IHC): Applied to examine the tissue distribution and cellular localization of SERPINB1 in formalin-fixed, paraffin-embedded (FFPE) tissue sections. SERPINB1 antibodies reveal cytoplasmic staining patterns in various cell types, particularly in immune cells such as neutrophils and macrophages .

• Immunofluorescence (IF): Employed to visualize subcellular localization, especially to track nuclear translocation upon activation.

• Functional studies: Used in knockdown or overexpression experiments to investigate SERPINB1's role in cellular processes like inflammation, apoptosis, and cell migration .

• Prognostic and diagnostic research: Applied to evaluate SERPINB1 expression as a potential biomarker in diseases like cancer and inflammatory conditions .

How should researchers select the appropriate SERPINB1 antibody for their specific applications?

When selecting a SERPINB1 antibody, researchers should consider several critical factors to ensure experimental success:

• Target species specificity: Confirm that the antibody recognizes SERPINB1 from your species of interest. Available antibodies have been validated for human samples, but cross-reactivity with mouse and other species may vary significantly .

• Application compatibility: Verify that the antibody has been validated for your intended application (WB, IHC, IF, etc.). For example, ab47731 from Abcam has been validated for Western blot and IHC-P applications with human samples .

• Epitope location: Consider which region of SERPINB1 the antibody targets, especially if you're studying specific domains or post-translational modifications. The reactive site loop region (approximately amino acids 303-310) is particularly important for SERPINB1 function .

• Clonality: Polyclonal antibodies (like ab47731) offer broader epitope recognition, while monoclonal antibodies provide higher specificity for a single epitope .

• Published validation: Review published studies that have used the antibody successfully. For instance, HPA018871 from Sigma-Aldrich has been cited in research examining SERPINB1's role in predicting chemotherapy response in melanoma and its decreased expression in hepatocellular carcinoma .

• Validation data: Examine the manufacturer's validation data, including Western blots showing the expected molecular weight (approximately 43-47 kDa for SERPINB1) and positive/negative control data .

What are the optimal protocols for validating a SERPINB1 antibody before experimental use?

A robust validation strategy for SERPINB1 antibodies should include:

• Positive and negative controls:

  • Positive: Cell lines or tissues known to express SERPINB1 (neutrophils, macrophages, lung tissue)

  • Negative: SERPINB1 knockout cells/tissues or cells treated with SERPINB1-specific siRNA

• Western blot validation:

  • Verify the molecular weight (43-47 kDa and occasionally a 65 kDa band)

  • Test multiple antibody dilutions (starting with 1:1000 is often appropriate)

  • Include a loading control

• Immunohistochemistry validation:

  • Test on tissues with known SERPINB1 expression patterns (spleen shows cytoplasmic staining in both red and white pulp)

  • Use standardized protocols such as the DAKO Autostainer Plus system with appropriate antigen retrieval

  • Include proper blocking steps (e.g., 3% H₂O₂ in methanol and protein blocks)

• Functional validation:

  • Confirm that antibody-mediated inhibition or immunodepletion alters expected SERPINB1 functions

  • Correlate antibody staining with functional readouts in experimental systems

• Specificity tests:

  • Pre-absorption with the immunizing peptide should eliminate specific staining

  • Compare with other validated SERPINB1 antibodies

• Cross-reactivity assessment:

  • Test on closely related family members (other serpins) to ensure specificity

What are the critical methodological considerations when using SERPINB1 antibodies in immunohistochemistry?

For optimal immunohistochemistry results with SERPINB1 antibodies, researchers should consider:

• Tissue preparation and fixation:

  • Formalin-fixed, paraffin-embedded (FFPE) tissues are commonly used

  • Proper fixation duration is critical to preserve epitope accessibility

• Antigen retrieval:

  • Heat-induced epitope retrieval using citrate buffer (pH 6.0) is effective for SERPINB1 detection

  • Using standardized protocols like the Dako 3-in-1 AR buffer in a PT link system

• Blocking steps:

  • Peroxidase blocking (3% H₂O₂ in methanol for 10 minutes)

  • Protein blocking (e.g., Dako Protein block containing 0.25% casein in PBS for 10 minutes)

• Antibody concentration and incubation:

  • For ab47731, a concentration of 2μg/ml has been validated

  • Incubation time of 20 minutes at room temperature is typically sufficient

  • For manual staining, optimization of primary antibody concentration and incubation time is recommended

• Detection system:

  • Signal amplification systems (like Dako Envision Flex) can enhance sensitivity

  • Colorimetric detection with diaminobenzidine (DAB) for 5 minutes

• Counterstaining:

  • Light hematoxylin counterstaining provides contrast without obscuring specific staining

• Expected staining pattern:

  • SERPINB1 typically shows cytoplasmic staining

  • In spleen, staining occurs in both red and white pulp

• Controls:

  • Include positive and negative tissue controls in each staining run

  • Consider technical negative controls (omitting primary antibody)

How should Western blot protocols be optimized for detecting SERPINB1 protein?

For optimal Western blot detection of SERPINB1:

• Sample preparation:

  • Use appropriate lysis buffers containing protease inhibitors

  • Load adequate protein amounts (typically 20-30 μg total protein per lane)

• Gel percentage and running conditions:

  • 10-12% SDS-PAGE gels are suitable for resolving SERPINB1 (43-47 kDa)

  • Include molecular weight markers spanning the 40-70 kDa range to capture potential post-translationally modified forms

• Transfer conditions:

  • Semi-dry or wet transfer systems work well

  • Transfer time should be optimized for proteins in the 40-50 kDa range

• Blocking:

  • 5% non-fat dry milk or BSA in TBST is typically effective

  • Block for 1 hour at room temperature or overnight at 4°C

• Primary antibody incubation:

  • For ab47731, a 1:1000 dilution has been validated

  • Incubate overnight at 4°C for optimal results

• Expected band patterns:

  • Main band at approximately 43-47 kDa (predicted size: 43 kDa)

  • Additional band may be observed at 65 kDa

  • Band pattern may vary depending on cell/tissue type and physiological state

• Controls:

  • SERPINB1 knockdown or knockout samples as negative controls

  • Cell lines known to express SERPINB1 (e.g., MH-S cells) as positive controls

• Stripping and reprobing:

  • If examining multiple proteins, mild stripping conditions are recommended to preserve epitopes

What is the role of SERPINB1 in immunological research and how can antibodies help investigate these functions?

SERPINB1 plays several critical roles in immunology that can be investigated using specific antibodies:

• Neutrophil regulation and survival:

  • SERPINB1 is highly expressed in neutrophils and protects these cells from their own granular proteases

  • Antibodies can be used to track SERPINB1 levels during neutrophil maturation, activation, and apoptosis

  • Research shows knockout mice have decreased neutrophil viability, supporting SERPINB1's role as a protector of neutrophil populations

• Inflammation resolution:

  • SERPINB1 is important in resolving chronic inflammatory lung and bowel diseases

  • Antibodies can monitor SERPINB1 expression and localization during inflammation resolution

  • Studies in SERPINB1-deficient mice show they fail to efficiently clear bacteria due to deficient neutrophil recruitment and increased protease release

• Innate immune regulation:

  • SERPINB1 negatively regulates type I interferon signaling while positively regulating autophagy

  • Antibodies can help investigate these dual regulatory roles in different cell types

  • Specifically, SERPINB1 has been shown to promote Senecavirus A replication by regulating both innate immunity and autophagy pathways

• T cell regulation:

  • SERPINB1 regulates IL-17+ γδ and CD4+ T cell populations

  • Antibodies can track SERPINB1 expression during T cell differentiation and activation

  • Research demonstrates SERPINB1 serves as an endogenous restraint to limit untoward expansion of lymphocytes with a Th17 phenotype

• Dual enzymatic activities:

  • SERPINB1 possesses both antiprotease and endonuclease activities

  • Domain-specific antibodies can help distinguish between these functions in different cellular contexts

  • The protein's endonuclease activity (L-DNase II) is unveiled after cleavage of its reactive site loop

How does SERPINB1 contribute to viral pathogenesis and how can this be studied using antibodies?

SERPINB1 has emerged as a significant player in viral pathogenesis through several mechanisms that can be investigated using antibodies:

• Promotion of viral replication:

  • SERPINB1 has been shown to promote Senecavirus A (SVA) replication

  • Antibodies can be used to monitor SERPINB1 expression levels during viral infection cycles

  • Overexpression and knockdown experiments combined with antibody detection help establish causality between SERPINB1 levels and viral replication efficiency

• Modulation of interferon signaling:

  • SERPINB1 negatively regulates type I interferon signaling pathways

  • Antibodies can track SERPINB1 interactions with key components of this pathway

  • Co-immunoprecipitation experiments using SERPINB1 antibodies can identify binding partners in the interferon signaling cascade

• Regulation of autophagy:

  • SERPINB1 positively regulates autophagy via AKT/mTOR signaling cascades

  • Immunofluorescence with SERPINB1 antibodies can examine colocalization with autophagy markers

  • Western blotting can monitor correlations between SERPINB1 levels and autophagy-related proteins

• Key domain identification:

  • The 303LTGMSEAR310 region of SERPINB1 is essential for SVA replication, with Met 306 (M306) and Ser 307 (S307) being key amino acids

  • Domain-specific antibodies can help investigate the importance of these regions in different viral contexts

  • Mutations of these key amino acids can be tracked using specific antibodies

• Influenza infection models:

  • In influenza virus respiratory infection, mortality and morbidity are elevated in serpinb1a−/− mice

  • Antibodies can monitor changes in SERPINB1 expression during infection progression

  • Immunohistochemistry can reveal tissue-specific changes in SERPINB1 distribution during infection

• IL-17+ T cell regulation:

  • Both the number and proportion of IL-17+ γδ T cells, which contribute to influenza pathogenicity, are increased in serpinb1a−/− mice

  • Flow cytometry with SERPINB1 antibodies can assess correlations between SERPINB1 expression and T cell activation states

What techniques can be used to study the dual functions of SERPINB1 as both a protease inhibitor and L-DNase II?

Investigating SERPINB1's dual roles requires specialized techniques:

• Conformational state-specific antibodies:

  • Develop or select antibodies that specifically recognize either the native (serpinB1) or cleaved (L-DNase II) forms

  • These can distinguish between the protease inhibitor and endonuclease activities in situ

• Nuclear translocation studies:

  • Use immunofluorescence to monitor the translocation of cleaved SERPINB1 (L-DNase II) to the nucleus

  • The bipartite nuclear localization signal becomes exposed upon reactive site loop cleavage

  • Time-lapse imaging with fluorescently tagged antibodies can capture this dynamic process

• Activity assays:

  • Protease inhibitory activity: Measure the inhibition of target proteases (elastase, cathepsin G) in the presence of SERPINB1

  • Endonuclease activity: DNA fragmentation assays to detect L-DNase II activity

  • Correlation of these activities with antibody staining patterns provides functional validation

• Cleavage-site mutants:

  • Generate SERPINB1 variants with mutations in the reactive site loop to prevent cleavage

  • Use antibodies to compare the localization and function of mutant vs. wild-type SERPINB1

• Co-localization studies:

  • Dual immunostaining to examine SERPINB1 co-localization with proteases or DNA

  • Super-resolution microscopy to precisely determine subcellular localization

• Apoptosis investigation:

  • SERPINB1 transforms into L-DNase II during apoptosis

  • Antibodies can track this conversion in cells undergoing programmed cell death

  • Correlate with other apoptotic markers to establish temporal relationships

What are the common challenges when working with SERPINB1 antibodies and how can they be overcome?

Researchers may encounter several challenges when working with SERPINB1 antibodies:

• Multiple band detection in Western blotting:

  • Challenge: SERPINB1 may appear as multiple bands (43-47 kDa and 65 kDa)

  • Solution: Verify specificity through knockout/knockdown controls and use multiple antibodies targeting different epitopes to confirm identity

• Cross-reactivity with other serpins:

  • Challenge: The serpin family has structural similarities that may cause cross-reactivity

  • Solution: Test antibody specificity against recombinant proteins of related serpins; use peptide competition assays to confirm specificity

• Distinguishing native vs. cleaved forms:

  • Challenge: SERPINB1 undergoes conformational changes upon cleavage that affect epitope accessibility

  • Solution: Use antibodies that specifically recognize either native or cleaved forms, or employ activity-based assays to distinguish functional states

• Variable expression levels:

  • Challenge: SERPINB1 expression varies significantly across cell types and conditions

  • Solution: Include appropriate positive controls (neutrophils, macrophages) and optimize detection sensitivity

• Nuclear translocation detection:

  • Challenge: The cleaved form (L-DNase II) translocates to the nucleus, requiring detection in different cellular compartments

  • Solution: Use subcellular fractionation techniques combined with Western blotting or immunofluorescence with nuclear counterstains

• Species cross-reactivity limitations:

  • Challenge: Antibodies may have limited cross-reactivity across species

  • Solution: Verify species reactivity before use; murine SERPINB1 (serpinb1a) may require specific antibodies

• Post-translational modifications:

  • Challenge: SERPINB1 may undergo modifications affecting antibody recognition

  • Solution: Use multiple antibodies targeting different regions; consider phospho-specific antibodies if studying regulated forms

How should researchers interpret conflicting data on SERPINB1 expression and function across different studies?

When faced with contradictory findings about SERPINB1:

• Consider methodological differences:

  • Different antibodies may recognize distinct epitopes or conformational states

  • Compare antibody specifications, dilutions, and detection methods across studies

  • Evaluate sample preparation methods, as they can affect epitope accessibility

• Examine cellular context:

  • SERPINB1 functions differ across cell types (neutrophils vs. lymphocytes)

  • Expression levels vary by several logs across immune cell populations

  • Cell activation states significantly impact SERPINB1 expression and function

• Assess disease state influence:

  • Inflammatory conditions alter SERPINB1 expression and localization

  • SERPINB1 can be found in bronchoalveolar lavage fluid during lung inflammatory diseases

  • Its role may shift from protective to pathogenic depending on disease context

• Consider dual functionality:

  • SERPINB1's dual roles as protease inhibitor and endonuclease may lead to apparently contradictory findings

  • Determine which function was being measured in each study

• Evaluate knockout model differences:

  • Complete knockout vs. conditional knockout models may yield different phenotypes

  • Myeloid-specific conditional knockouts provide more precise information about cell-specific functions

  • Compensatory mechanisms may differ between acute knockdown and germline deletion

• Scrutinize viral-host interactions:

  • SERPINB1's role during viral infections is complex and virus-specific

  • Different viruses may exploit or be inhibited by SERPINB1 through distinct mechanisms

What emerging techniques could enhance SERPINB1 antibody applications in research?

Several cutting-edge approaches could advance SERPINB1 research:

• Conformational state-specific nanobodies:

  • Development of small antibody fragments that distinguish between native and cleaved SERPINB1

  • These could enable live-cell tracking of SERPINB1's functional transition

• Proximity labeling approaches:

  • BioID or APEX2 fusions with SERPINB1 combined with antibody detection to identify protein interaction networks

  • This would reveal context-specific binding partners in different cellular conditions

• Super-resolution microscopy:

  • Advanced imaging techniques using fluorescently-labeled antibodies to precisely track SERPINB1 subcellular localization

  • Could reveal previously undetected microdomains of SERPINB1 function

• Single-cell proteomics:

  • Combining flow cytometry with SERPINB1 antibodies to analyze expression at the single-cell level

  • Would reveal heterogeneity in SERPINB1 expression across immune cell populations

• CRISPR-based reporter systems:

  • Endogenous tagging of SERPINB1 to monitor expression without antibody staining

  • Would allow longitudinal tracking in living systems

• Tissue-specific conditional knockout models:

  • Combined with antibody validation to understand cell-type specific functions

  • Would help resolve contradictory findings across different experimental systems

What are the promising therapeutic implications of SERPINB1 research that could be facilitated by antibody-based studies?

SERPINB1 research has several potential therapeutic applications:

• Inflammatory disease modulation:

  • SERPINB1 plays a critical role in resolving inflammatory lung and bowel diseases

  • Therapeutic antibodies could be developed to monitor treatment efficacy

  • Recombinant SERPINB1 administration normalized bacterial clearance in knockout mice

• Cancer prognosis and treatment:

  • SERPINB1 expression is predictive for sensitivity and outcome of cisplatin-based chemotherapy in melanoma

  • Decreased expression correlates with tumor invasion and poor prognosis in hepatocellular carcinoma

  • Diagnostic antibodies could help stratify patients for appropriate therapies

• Viral infection management:

  • SERPINB1 modulates innate immunity and autophagy during viral infections

  • The 303LTGMSEAR310 region, particularly M306 and S307, are key for viral replication

  • Antibodies targeting specific domains could help develop antivirals that disrupt virus-host interactions

• Neutrophil-mediated disease treatment:

  • SERPINB1 protects against excess neutrophil serine proteases (NSPs) that play a central role in inflammatory pulmonary disease

  • Monitoring SERPINB1 levels with antibodies could help guide neutrophil-targeting therapies

• Apoptosis regulation:

  • The SERPINB1/L-DNase II transition occurs during apoptosis

  • Antibodies distinguishing these forms could help identify cells undergoing programmed cell death

  • This could inform therapeutic approaches targeting cellular turnover in disease states

• Beta-cell proliferation:

  • When secreted, SERPINB1 promotes the proliferation of beta-cells via its protease inhibitory function

  • Antibodies could help track this process in diabetic models

  • May lead to novel diabetes interventions

These therapeutic directions highlight the importance of developing specific, well-characterized antibodies that can distinguish between SERPINB1's various functional states and localization patterns in different disease contexts.